Illumina: Neutral Stance Amid Emerging Roche Competition and Incremental NovaSeq X Enhancements
at www.tipranks.com (Mon, 23-Mar 7:55 AM)
CMS Reimbursement Approval Expands Access to Illumina's TruSight Oncology Test—Will This Transform Precision Cancer Care?
Market Chameleon (Tue, 20-Jan 9:21 AM)
Illumina Launches Billion Cell Atlas—A Groundbreaking Step for AI-Driven Drug Discovery and Precision Medicine
Market Chameleon (Tue, 13-Jan 9:27 AM)
